Guglielmi detachable coil treatment is becoming an accepted alternative to microsurgical clipping for select intracerebral aneurysms. Resolution of oculomotor nerve paresis (ONP) after endovascular packing was claimed to be complete in two prior series, with three and six cases. We describe the evolution of ONP after Guglielmi detachable coil treatment of posterior communicating artery aneurysms, and we search for endovascular and patient factors correlated with the degree of functional nerve recovery. METHODS: Twelve cases of ONP attributable to posterior communicating artery aneurysms were treated with Guglielmi detachable coils between 1999 and 2002. Eleven patients were available for follow-up monitoring. The degree of ONP was recorded at admission, at discharge, after 3 months, and at yearly intervals thereafter. The size of the aneurysm, the duration of ONP before coiling, the degree of coiling, age, and the presence of other microvascular risk factors were correlated with the degree of nerve recovery. RESULTS: Complete resolution of ONP did not occur in any of the 11 cases in this series. However, residual oculomotor nerve deficits did not cause diplopia with primary gaze for 10 of 11 patients. Clinically significant ptosis did not persist for any of the patients. The pupil remained minimally affected in all cases. CONCLUSION: Although mass effect remains after endovascular packing, oculomotor nerve dysfunction improves comparably to the recovery observed after surgical clipping. Contrary to previous reports, typical residual oculomotor nerve deficits persist. Older age and the presence of microvascular risk factors seem to be detrimental to ONP recovery.
ndovascular Guglielmi detachable coil (GDC) therapy has an increasingly important role as an alternative to microsurgical clipping for treatment of select intracerebral aneurysms (8) . Although it is more comfortable for the patient and is often associated with lower complication rates, coiling is not thought to resolve all of the mass effect caused by aneurysms. The proposed mechanism by which coiling relieves adjacent-structure pressure is the lessening of pulsations after aneurysm thrombosis. Resolution of oculomotor nerve paresis (ONP) after endovascular packing was claimed to be complete in two prior series, describing a combined total of nine cases (1, 7) . We describe a series of 11 patients who were treated with endovascular packing for posterior communicating artery (PComA) aneurysms, with close neuro-ophthalmological follow-up monitoring.
PATIENTS AND METHODS
Two hundred thirty small or large aneurysms among 185 patients were treated with endovascular coiling at our institution between 1999 and 2001. A total of 12 patients experienced ONP resulting from PComA aneurysms treated with GDCs. One patient died shortly after the procedure, as a result of complications of cardiovascular disease. The remaining 11 patients were prospectively exam-ined by a neuro-ophthalmologist (HS-K) and by an interventional neuroradiologist (SM).
All endovascular procedures were performed by one interventional neuroradiologist (SM), using general anesthesia, live simultaneous road-mapping (mainly via biplane imaging), and systemic heparinization (adjusted to an activated clotting time of 250-300 s). All treatments were performed via the transfemoral route; 6-French guiding catheters were positioned in the internal carotid artery. Tracker-10, Tracker-18, or Excel-14 microcatheters (Boston Scientific/Target, Fremont, CA) were used to treat the aneurysms with GDC-10 or GDC-18 coils (Boston Scientific/Target). At the end of the procedure, all patients were transferred to the neurosurgical intensive care unit for observation. Heparin was administered for 24 hours after the procedure. The duration of hospitalization depended on the course and severity of the disease. One patient with an unruptured aneurysm was discharged within 3 days. The patients with subarachnoid hemorrhage were monitored for the presence of vasospasm with transcranial Doppler ultrasonography and were treated prophylactically with nimodipine. Digital subtraction angiography was scheduled at 3 and 15 months, and magnetic resonance imaging assessments were scheduled at yearly intervals thereafter. The completeness of aneurysm closure was noted. One patient demonstrated coil compaction (from 100% to 90% occlusion) at the 3-month follow-up angiographic examination and was retreated with GDCs.
The interventional radiologist prospectively recorded information on the clinical Hunt and Hess grade and the aneurysm size. The neuro-ophthalmologist prospectively recorded the duration of ONP before treatment for each patient and the degree of ONP at admission before treatment, at discharge, after 3 months, and at yearly intervals thereafter. Patient age and the presence of other microvascular risk factors (smoking, diabetes mellitus, and hypertension) were noted. Aneurysm and patient risk factors were correlated with the degree of ONP recovery by using two different analyses, i.e., effect size analysis (Cohen's D test) (2) and Fisher's exact test. An effect size (Cohen's D value) of more than 0.3 was considered to indicate a small meaningful effect. An effect size of 0.5 or more signified a medium-size effect. The degree of ONP was classified into three categories, as follows: 1) minimal residual ONP, defined as an upgaze deficit (trace underaction of the superior rectus muscle) with mild diplopia present only during looking up; 2) moderate residual ONP, with diplopia present with upgaze (superior rectus muscle) or downgaze (inferior rectus muscle) but not primary gaze, or 3) significant residual diplopia with primary gaze, with a slight adduction deficit (medial rectus muscle) in addition to a mild upgaze deficit.
RESULTS
Follow-up data were available for all 11 patients, for periods ranging from 8 months to 3 years. The ages of the patients ranged from 30 to 77 years. A history of smoking was noted for seven patients. Hypertension was present for seven patients, two of whom were also being treated for diabetes mellitus. Five patients had a large PComA aneurysm as the cause of their ONP, whereas six had a small aneurysm of less than 1 cm in its largest diameter. Three patients were admitted in Hunt and Hess Grade III, seven were admitted in Grade I or II, and one patient was admitted without aneurysm rupture. All patients exhibited complete pupil-involving ONP, beginning 3 to 23 days before treatment (mean, 9 d). The duration of ONP before coiling for each patient is presented in Table 1 . Severe ipsilateral retro-orbital pain and headache was a prominent feature for five of the patients (45%), beginning days to months before ONP.
Complete recovery of oculomotor nerve function was not observed for any of the 11 patients in this series. The ONP recovery results are detailed in Table 1 . Residual oculomotor nerve motor deficits did not cause diplopia with primary gaze (looking straight ahead) for 10 of 11 patients. Four patients exhibited minimal residual ONP. Six patients exhibited moderate residual ONP, and one patient complained of significant residual diplopia with primary gaze as well as upgaze and downgaze.
Mild ptosis of 1 to 2 mm, compared with the contralateral eye, persisted for all patients, but this did not cause any clinical disability because the pupil was not covered. The pupil remained minimally affected for all patients. All patients exhibited a residual sluggish direct reaction to light in the affected pupil. The 11 patients exhibited mild anisocoria, with the affected pupil being persistently 1.5 to 5 mm larger than the contralateral pupil. Aberrant regeneration, in the form of a lid lag with downgaze (pseudo-von Graefe's sign), was observed for 3 of 11 patients (27%).
Endovascular features of the 11 PComA aneurysms are detailed in Table 2 . There were five patients with large aneurysms (Ͼ10 mm), three of whom were left with moderate ONP defects. Of the six patients with small aneurysms, three were left with moderate ONP (P ϭ 0.65, Cohen's D ϭ 0.46). Two of the four patients with aneurysms coiled more than 10 days after the onset of symptoms and five of the seven patients with aneurysms treated within 10 days after ONP onset demonstrated residual moderate or significant ONP at the 1-year follow-up assessments (P ϭ 0.470, Cohen's D ϭ 0.26). Of the six patients whose aneurysms were completely closed during the initial treatment, three exhibited minimal ONP at 1 year. Of the four patients with nearly complete initial occlusion (95-99%), two exhibited minimal residual ONP. One patient experienced a cerebral stroke resulting from vasospasm during her initial coiling procedure. The procedure was stopped, and the patient was left with 50% occlusion of her aneurysm. Ten days later, a second endovascular treatment was performed, with nearly complete occlusion.
On repeat angiograms obtained at 3 months, 9 of 11 patients demonstrated complete or nearly complete closure of their aneurysms. Coil compaction, leading to 90% occlusion or less, occurred for two patients. One of those two patients (Patient 8) was left with significant ONP, which did not improve after recoiling ( Table 2 ). The other patient was the aforementioned patient with vasospasm and stroke (Patient 6); she elected not to be retreated ( Table 2) . On 3-month angiograms, two aneurysms exhibited slight coil compaction, from complete to nearly complete occlusion. One of those two patients remained with unchanged minimal ONP, whereas the other was left with a stable moderate oculomotor nerve deficit. We did not observe a correlation between the Hunt and Hess grade at the time of presentation and the degree of eventual ONP recovery. Five of six patients older than 60 years were left with residual moderate or significant ONP. Two of the five younger patients demonstrated persistent moderate ONP (P ϭ 0.197). When age was analyzed as a continuous variable with respect to the degree of ONP recovery, it seemed that older patients recovered less than did their younger counterparts (Cohen's D ϭ 0.50). Four of the seven smokers were left with moderate oculomotor nerve deficits, whereas three of the four nonsmokers exhibited similar residual deficits (P ϭ 0.53). Of the seven patients left with more than minimal oculomotor nerve deficits, six had either hypertension or hypertension and diabetes mellitus; minimal ONP occurred for one of the hypertensive patients (P ϭ 0.088). Cohen's D value correlating the presence of microvascular risk factors (0, no microvascular risk factors; 1-3, presence of smoking, hypertension, and/or diabetes mellitus) with the degree of ONP recovery was 0.58. Table 3 presents patient risk factors and the degree of ONP recovery.
DISCUSSION
The resolution of ONP after endovascular packing of PComA aneurysms was reported to be complete by Mavilio et al. (7) and Birchall et al. (1), who reported six and three cases, respectively. Those nine patients did not undergo full recordings of motor defects in all cardinal fields of gaze or assessments of levator palpebrae muscle and pupil function. The patients in those two series were reported to have experienced resolution of diplopia with primary gaze, as did most (91%) of the patients in this series. Incomplete resolution of ONP after surgical clipping has been well documented (3) (4) (5) (6) 9) . The typical pattern of recovery observed in our series, in which the levator palpebrae and medial rectus muscles demonstrated rapid recovery and the parasympathetic fibers of the pupil and the superior and inferior rectus muscles lagged behind, was previously described by Hamer (4) . In a recent report by Yanaka et al. (10) , describing 15 patients who were treated for small unruptured aneurysms (14 after microsurgical clipping and 1 after intravascular embolization), 6 patients (37.5%) were noted to exhibit incomplete ONP recovery, whereas 2 (12.5%) exhibited no change. The fact that Yanaka et al. (10) reported 43.8% complete ONP recovery might be attributable to the fact that only small unruptured aneurysms were included. Those authors also observed that a shorter interval between the onset of ONP and treatment was beneficial for ONP recovery. It is possible that time was not demonstrated to be an important factor in our series because the mean interval between the onset of treatment and ONP was 9 days, compared with a mean of 17 days in the series reported by Yanaka et al. (10) .
Careful neuro-ophthalmological follow-up monitoring in our series revealed that true complete cure of ONP did not occur often. We hope that recognition of the typical residual deficits and monitoring of those deficits after endovascular coiling can assist endovascular surgeons in the early recognition of coil compaction and aneurysm reopening. Without regular neuro-ophthalmological follow-up monitoring, it may be difficult to recognize subtle signs of worsening or a lack of expected improvement. As Cohen (2) noted, statistical significance (P values) is strongly influenced by sample size and may thus confound any interpretation. A more appropriate approach for small samples is the use of effect size (Cohen's D value), which represents the standardized mean difference between groups. Effect size is not influenced by sample size and thus provides valid reliable estimates of effects. An effect size of 0.3 or more is considered to indicate a small meaningful effect, which should become statistically significant with a larger sample size. In addition to this analysis, we performed the more widely known Fisher's exact test. Each analysis confirmed the results of the other. It seems that a pattern of patient factors predicting poor recovery can be recognized. Eighty-three percent of patients older than 60 years were left with moderate or significant oculomotor nerve deficits, compared with 40% of younger patients (P ϭ 0.197). Cohen's D test confirmed the importance of age as a poor prognosticator of nearly complete recovery. Microvascular risk factors other than age (hypertension, diabetes mellitus, and a history of smoking) were also observed more often among patients with moderate or severe residual ONP. Twenty-five percent of patients without hypertension or diabetes mellitus remained with moderate ONP, compared with 86% of patients with those risk factors (P ϭ 0.088). Cohen's D test demonstrated that patients with more microvascular risk factors had lesser chances of nearly complete recovery (Cohen's D ϭ 0.67). Fisher's exact test did not demonstrate effects of aneurysm size or duration of ONP before coiling on the degree of ONP recovery in this small series, which might preclude the recognition of significant statistical trends. However, Cohen's D test demonstrated an almost medium-size effect of size on ONP recovery (Cohen's D ϭ 0.46). Coil compaction to nearly complete occlusion after 3 months could not be demonstrated to affect outcomes. Despite the small number of such cases, it should be noted that two patients whose coils compacted to partial (50%) or 90% occlusion did experience worse outcomes. We hope that future reports will indicate whether poor ONP recovery might suggest significant coil compaction among patients who are expected to fare better.
CONCLUSIONS
Small residual oculomotor nerve deficits, mainly diplopia with upward or downward gaze, are often observed after endovascular coiling. This finding is contrary to the results of previous small studies of outcomes after coiling and is similar to the results observed after surgical clipping. Older age and the presence of microvascular risk factors might decrease the chances of ONP recovery. 
